| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Australia | 1 | |
| #5 | Canada | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bollag Werner | 16 |
| #2 | Sinigaglia Francesco | 2 |
| #3 | Klaus Michael | 2 |
| #4 | Ott Fritz | 2 |
| #5 | Panina-Bordignon Paola | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CA2622600A1 | Rxr agonists and antagonists, alone or in combination with ppar ligands, in the treatment of metabolic and cardiovascular diseases | |
| US2006264504A1 | Treatment of cell-mediated immune diseases | |
| US2009016991A1 | Rxr Antagonist Treatment Against Multiple Sclerosis | |
| EP1621191A1 | Treatment of inflammatory diseases by RXR Antagonists | |
| EP0908179A1 | Treatment of cell-mediated immune diseases |